
ASCO 2019: New standard regimen for women with uterine carcinosarcomas
Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin…
Results from the phase III NRG Oncology clinical trial GOG 0261 comparing paclitaxel plus carboplatin…